How has been the historical performance of Zydus Lifesci.?

Answer:The historical performance of Zydus Lifesci shows a consistent growth trajectory in net sales and profits over the years, with significant increases noted in the latest fiscal year ending March 2025.

Breakdown:
Zydus Lifesci's net sales have risen from 13,165.60 Cr in March 2019 to 23,241.50 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar pattern, increasing from 13,165.60 Cr in March 2019 to 23,241.50 Cr in March 2025. The company's operating profit (PBDIT) also saw substantial growth, climbing from 2,983.50 Cr in March 2019 to 7,328.00 Cr in March 2025, indicating improved operational efficiency. Profit before tax surged from 2,382.10 Cr in March 2019 to 6,026.70 Cr in March 2025, while profit after tax increased from 1,851.80 Cr to 4,614.80 Cr in the same period. The earnings per share (EPS) rose significantly from 18.05 in March 2019 to 44.99 in March 2025, showcasing enhanced shareholder value. On the balance sheet, total assets grew from 22,833.70 Cr in March 2020 to 34,857.90 Cr in March 2025, while total liabilities increased from 22,833.70 Cr to 34,857.90 Cr, reflecting the company's expanding operations. Cash flow from operating activities improved from 1,281.00 Cr in March 2019 to 3,227.00 Cr in March 2024, indicating stronger cash generation capabilities. Overall, Zydus Lifesci has demonstrated robust growth in sales, profits, and asset base over the years.